Title:
ORALLY ADMINISTERED DOSAGE FORMS OF FUSED GABA ANALOG PRODRUGS HAVING REDUCED TOXICITY
Document Type and Number:
WIPO Patent Application WO2004053192
Kind Code:
A9
Abstract:
The present invention provides an extended release oral dosage form of prodrugs of fused GABA analogs of reduced toxicity. The dosage forms are particularly useful in administering those fused GABA analogs that are metabolized to form an aldehyde. The dosage forms of the invention are useful for treating or preventing diseases and/or disorders for which fused GABA analog are known to be therapeutically effective.
Inventors:
GALLOP MARK A
Application Number:
PCT/US2003/039521
Publication Date:
November 04, 2004
Filing Date:
December 11, 2003
Export Citation:
Assignee:
XENOPORT INC (US)
International Classes:
A61K31/225; A61K47/48; C23C22/07; (IPC1-7): A61K31/225
Download PDF:
Previous Patent: WO/2004/053190
Next Patent: METAL OXIDE FILM, DYE-SENSITIZED SOLAR CELL AND METHOD FOR MANUFACTURING SAME
Next Patent: METAL OXIDE FILM, DYE-SENSITIZED SOLAR CELL AND METHOD FOR MANUFACTURING SAME